Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.

Vaccine(2019)

引用 13|浏览21
暂无评分
摘要
•First in humans study with a live attenuated pandemic delNS1-H5N1 vaccine.•Significant serum antibody titers as measured by HAI and MNA after two immunizations.•DelNS1-H5N1 well tolerated and safe in healthy male and female participants.•No vaccine virus re-isolated in participants after one immunization.
更多
查看译文
关键词
Influenza,NS1,Intranasal,H5N1,Live attenuated,Replication-deficient,Reverse genetics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要